Results 11 to 20 of about 162,890 (205)

Sources of CNS tumor heterogeneity [PDF]

open access: yesOncoscience, 2014
Central nervous system tumors are marked with high intra- and inter-tumoral heterogeneity. For instance, an integrative large scale gene expression study performed in 2010 revealed 4 subtypes glioblastoma multiforme (GBM) with differential responses to treatment and prognosis [1].
Fuyi, Chen   +2 more
openaire   +2 more sources

Tumors in von Hippel–Lindau Syndrome: From Head to Toe—Comprehensive State-of-the-Art Review [PDF]

open access: yes, 2018
Von Hippel–Lindau syndrome (VHL) is an autosomal-dominant hereditary tumor disease that arises owing to germline mutations in the VHL gene, located on the short arm of chromosome 3.
Bhalla, Sanjeev   +6 more
core   +1 more source

APPLICATION OF PHOTODYNAMIC THERAPY IN TREATMENT OF MALIGNANT NEOPLASMS OF THE CENTRAL NERVOUS SYSTEM

open access: yesПаёми Сино, 2020
World literature data dedicated to the problem of application of photodynamic therapy (PDT) in the neurooncology has been studied and analyzed, and also the prospects for development and improvement of surgical treatment for malignant neoplasms of CNS ...
A.A. SUFIANOV   +3 more
doaj   +1 more source

Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes

open access: yesActa Neuropathologica Communications, 2020
Four molecular types of rare central nervous system (CNS) tumors have been recently identified by gene methylation profiling: CNS Neuroblastoma with FOXR2 activation (CNS NB-FOXR2), CNS Ewing Sarcoma Family Tumor with CIC alteration (CNS EFT-CIC), CNS ...
Maria Łastowska   +13 more
doaj   +1 more source

Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts

open access: yesActa Neuropathologica Communications, 2019
The diagnosis and prognostication of glioblastoma (GBM) remain to be solely dependent on histopathological findings and few molecular markers, despite the clinical heterogeneity in this entity. To address this issue, we investigated the prognostic impact
Toru Umehara   +20 more
doaj   +1 more source

Citrate in Pediatric CNS Tumors? [PDF]

open access: yesAmerican Journal of Neuroradiology, 2008
In a subset of in vivo MR spectra acquired from pediatric brain tumors, we have observed an unassigned peak. The goal of this study was to determine the molecule of origin, and the prevalence and concentration of this chemical in various pediatric brain tumors.Single-voxel point-resolved spectroscopy (PRESS) spectra from 85 patients with brain tumors ...
Z A, Seymour   +4 more
openaire   +2 more sources

Intracranial mesenchymal tumor with (novel) COX14::PTEN rearrangement

open access: yesActa Neuropathologica Communications, 2023
Mesenchymal tumors of the central nervous system (CNS) include numerous entities, with different pathological features and biological behavior. Mesenchymal non-meningothelial tumors are rare and comprise neoplasms that are exclusive to the CNS or show ...
Antonio d’Amati   +14 more
doaj   +1 more source

Editorial: Spatiotemporal heterogeneity in CNS tumors [PDF]

open access: yesFrontiers in Immunology
Syed M. Faisal   +2 more
doaj   +2 more sources

Topical issues of the clinic of primary brain tumors

open access: yesМедицинский совет, 2019
The article is devoted to the issue of clinical and neurological features of primary brain tumors (PBT). PBT account for 2% of the total number of human tumors. PBT represent an urgent social problem, causing disability and mortality.
T. I. Ashkhatsava   +3 more
doaj   +1 more source

NECESSITY FOR A CUSTOMIZED NGS PANEL FOR ACCURATE DIAGNOSIS AND TARGETED THERAPIES IN PEDIATRIC GLIAL TUMORS

open access: yesHematology, Transfusion and Cell Therapy, 2021
Objective: Pediatric glial tumors comprise wide range pathologies which may mimic histomorphological features of each other's but generally have very diverse disease course. WHO Classification of Tumors of Central Nervous System (2016 and 2021) points to
Ayça Erşen Danyeli   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy